News
December 13, 2024

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences 

Regenstrief Institute will partner with Indiana University and other key bioscience organizations in the state to make significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. 

“IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Rachel Patzer, PhD, MPH, Regenstrief president and CEO. Through its efforts to translate research into practice, this partnership will lead to better health outcomes and improved health care across Indiana.”  

View the complete press release on Indiana University’s webpage 

Partners

Related News

infographic with statistics from press release

COVID vaccine reduces severity of illness, death for adults, especially among at-risk populations

CDC partnership study includes data from 8 states, 362 E.D.s and urgent care centers, 230 hospitals A new multi-state

Thomas Imperiale

Rectal location and postcolonoscopy colorectal cancer outcomes

Published in the JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Thomas Imperiale, M.D. This

Arthur Owora, PhD, MPH, and Malaz Boustani, M.D., MPH

New digital marker could improve childhood asthma detection

Researchers at the Indiana University School of Medicine and Regenstrief Institute have developed a more accurate and cost-effective method

Kosali Simon, PhD

Health care workforce recovery after the end of the COVID-19 emergency

The COVID-19 pandemic significantly disrupted health care employment, with effects that varied across subsectors. Initial impacts included a 6.9